Posted in | News | Building and Construction

Albemarle Completes Sale of French Facility

Jan 5 2009

Related Stories

Albemarle Corporation (NYSE: ALB) and International Chemical Investors Group ("ICIG") announced today that Albemarle Chemicals SAS, a wholly owned affiliate of Albemarle Corporation, has completed the sale of its facility in Port de Bouc, France to Azur Chimie SAS, a wholly owned affiliate of ICIG, effective December 31, 2008. Albemarle has transferred to Azur Chimie all equipment, buildings, land and certain other assets at the Port de Bouc, France plant. Azur Chimie will toll manufacture certain products for Albemarle. As a result of the sale, Albemarle expects to incur a pre-tax charge of approximately $25 to $30 million in the 4th quarter of 2008.

"We are very pleased to complete this transaction in such a timely and orderly fashion and to continue our mutually beneficial relationship with ICIG," said Ron Gardner, Vice President of Albemarle's Fine Chemicals segment. "This strategic divestiture will position us to better focus on our core business initiatives."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback